Research Article
HIV-Associated Oral Mucosal Melanin Hyperpigmentation: A Clinical Study in a South African Population Sample
Table 1
Demographic and immunological characteristics of the study population; all subjects were Black.
| | | No OMH () | HIV-OMH () |
| Age group |
≤30 years | 16 | 13.68% | 3 | 8.11% | 31–40 years | 49 | 41.88% | 12 | 32.43% | 41–50 years | 33 | 28.21% | 15 | 40.54% | >50 years | 19 | 16.24% | 7 | 18.92% |
| Gender | Female | 91 | 77.78% | 21 | 56.76% | Male | 26 | 22.22% | 16 | 43.24% |
| Smoking status | No | 114 | 97.44% | 30 | 81.08% | Yes | 3 | 2.56% | 7 | 18.92% |
| Snuff use | No | 114 | 97.44% | 34 | 91.89% | Yes | 3 | 2.56% | 3 | 8.11% |
| CD4+ T cell count (cells/mm3) | 0–199 | 71 | 60.68% | 21 | 56.76% | 200–499 | 32 | 27.35% | 12 | 32.43% | >499 | 13 | 11.11% | 4 | 10.81% | Unknown | 1 | 0.85% | 0 | 0.00% |
| Viral load | ≤1000 | 75 | 64.10% | 24 | 64.86% | >1000 | 42 | 35.90% | 13 | 35.14% |
|
|